{"name":"Indication Bioscience LLC","slug":"indication-bioscience-llc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMikgJBVV95cUxNcjBHN3hVWmhDdDRFS2JCekx5Z1pVQndlRjBjRkZDT2ZtYzVudVhjbThhR1BuX05fQ0pUMFRmWG1JWW85U0lDdnpfRVRzN2ZqU0llUmZySldPdDJBVF9sdlFYRWFmbjdKcWpxWWZjR1FsX2hTUFJ2b01ZMG1kRHVzTjdURFV0X0J5M1AtVGJ5WlcwMm90Z2JwcDduRWV4dVRfM2FzTTFkRS00NDAyY0k4YlowWk8xQ193YlFRX1JSSUN3S0VlZ0tvS1lKWnpHaHBJblAzejVIUlQ0N0lMNDlIOHhqRUI5TDYzZktpQklSOWdaYUlOU0JHaE9PR3NTWmI4aDU2Z1B3TTdPbEhpbU5Zemx3?oc=5","date":"2026-02-10","type":"pipeline","source":"BioSpace","summary":"Kashiv BioSciences and Intas Pharmaceuticals Sign an Exclusive Licensing and Supply Agreement for Complex Peptide Product in Europe, the UK & India - BioSpace","headline":"Kashiv BioSciences and Intas Pharmaceuticals Sign an Exclusive Licensing and Supply Agreement for Complex Peptide Produc","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitgFBVV95cUxORUFLdm82aTlnRkJIb0FHQk5DZXNsbEhsWlNKYnRzVjNEQzY1MkNBdTh3WmZIRTl0M2YtcWVLcHI4Z1A4VElqZ1FWejBZa2N4YXBBWXk4TmxyRjRCZUlwREhlWTh5b2ZYOWwtODZKSHJuRHNoR1lxakNDd2ctblJublAtNDJiVzFMbkxWS1ZrVV9Ra09WUU9TV0tQWTVneUVEd0poUGJGXzVOWXFNMjlhbzNyQXJyZw?oc=5","date":"2025-06-23","type":"deal","source":"Fierce Biotech","summary":"Sanofi signs €545M deal to explore Formation’s JAK/SYK inhibitor in new indication - Fierce Biotech","headline":"Sanofi signs €545M deal to explore Formation’s JAK/SYK inhibitor in new indication","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxOVnZ5V0syNmpxVmtaRkdmU2h2THNVM25ESEtFTGE3UTdhVlZ0R19qRkpMZERMSnp1bEQtQmFTRVhrX210Q1cxQWQ0SDRiU3RLQVRnZkNnRFkwa29PRWFZNzVBSDNRVzlkcjFGWll1UlpqV3lRSnh2UG1zOEZjMzVIZ24xLXpZVlVnZjdudHRDSHp1dGJLdXRmdEVhaDdyTXoxQXc?oc=5","date":"2025-03-05","type":"deal","source":"BioSpace","summary":"Acelyrin Rejects Concentra’s Buyout Offer in Favor of Alumis Merger - BioSpace","headline":"Acelyrin Rejects Concentra’s Buyout Offer in Favor of Alumis Merger","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivgFBVV95cUxQTVVodTJ0VUdMem1rSEFxR1U3TjRiVFVaRkJDUDJFSGM1ekJPSHl2UmZkZWsxQ1lMSHlwM0llQ0lFb25LUjhxajA2T0kxOUpBNExDUnZuRmNXdDZaZGNUa0F4MGpBUDRoa0FVeHBmVDlVSWNBV2Z2eXFkQVlTRHlKTU9WQ00yMjhyRm5MajROdVdvV1NFbWVBQmxKZWgzRkxyV1FleTB4ZmRxbHpzU0JQUU5WeHhfZlBsbldxbWVB?oc=5","date":"2025-02-19","type":"regulatory","source":"Fierce Pharma","summary":"FDA disrupts Harmony's expansion dreams for excessive sleepiness drug Wakix with refusal letter - Fierce Pharma","headline":"FDA disrupts Harmony's expansion dreams for excessive sleepiness drug Wakix with refusal letter","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMie0FVX3lxTE1iUVl3S0pYZlpmZWRiSC1nYWZ0QzQ5TkdXX2Y1WkhrUVBBRU9oUEJIU0ZkMHhpTTJiYmxEMTFQNGxaRVE0NC10YjU1Y25tOE9YLVhHNlpCU2xEQlhRR2N3alQtbXNnbmptaVdZV2xlb0hGZzRET2hvUmRsOA?oc=5","date":"2025-02-18","type":"trial","source":"Fierce Biotech","summary":"2024's top 10 clinical trial flops - Fierce Biotech","headline":"2024's top 10 clinical trial flops","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisgFBVV95cUxNQmNjcUhaNjNEZi1jSEhLWEhoY2FoREpQSlczbkt4aVF1Y0lWM2J2WG9OR29QSGRRc3NzVXJfb1dSaGVaaUFoMmZIRmhPQnNvOWZJR3E2ZVUyV2FOMGJEdlJKTW01YzQxRktDdlkzT2VXNlFYSzZFX0hjdjJRS3pqbEEybVdxLTFGVlg5UHhEQklZVktJY3Fyc3RPSFRnNjhPV2VnRm9vZFZzUmpQYld3OXNn?oc=5","date":"2025-02-10","type":"pipeline","source":"Fierce Pharma","summary":"With Teva competition heating up, Neurocrine's tame Ingrezza forecast spooks investors - Fierce Pharma","headline":"With Teva competition heating up, Neurocrine's tame Ingrezza forecast spooks investors","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMid0FVX3lxTE1QZWc4aC1ybDZQY1FqRUFKRFl3bWozSjNjMlFoZmZHWkFjZDIwV0ZiYS1pYUNpUUV1TGRpY19SV1ZFUWVReU8xVjJiU3JYazBpVXM2Z1pCV1VoZEpGYko0X3R2aDhsYk1oSWRqS3k4TFpJR2dTanIw?oc=5","date":"2024-10-31","type":"pipeline","source":"Fierce Biotech","summary":"The 2024 Biotech Graveyard - Fierce Biotech","headline":"The 2024 Biotech Graveyard","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivwJBVV95cUxNaEMtZGNsQkdZS2xMa0l1MWNsMHdGOFl4MG1ianQyOHZkUHFfYVBfN3ZRdEZDSVV1OG5SNXFrOER0TVFpUUt6MnZGamRUdjc2TnBYZG9zYi1aZnAxMXVtckxUZGtFaWZVS0psdDE3YWw3ekFHX3RfWGstTkR2bFdORzczRlBXdmcweDVIVU9wMnp0X2FMU1NnZHJ1Y0FmTFNPNnlEOGxmaUJ4OEY0Z0RKQnhsUlpvNF9aT2s2UmNMdDl2NkxfRHNJZ2xPRUV3THUyTDYwT3IzNHJtYjFFNUpwblpydFVDTWJzWnFwME13QmhoUTM5dkthZnBmM3ZPaXJZU2ZORlBlbURmeWFsRFI4RlVJTWFpN3YxMnY5NWNndEludmVOY1ZaLUxzVzZfNUtLTkVianowNFNubldldnZR?oc=5","date":"2022-02-25","type":"deal","source":"PR Newswire","summary":"Biohaven Acquires Kv7 Ion Channel Platform for the Treatment of Epilepsy and Other Neurologic Disorders From Channel Biosciences, a Subsidiary of Knopp Biosciences - PR Newswire","headline":"Biohaven Acquires Kv7 Ion Channel Platform for the Treatment of Epilepsy and Other Neurologic Disorders From Channel Bio","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMid0FVX3lxTFBqUDVNVG95ZFZRd3lSSHpYaFliS1JRZkRUVTZzRDVGc1ZyTkhxajdvX21FRERCR0hQNTJrcjNqNERDZC1jS0xwUDhkVm4tVEF1UmtGR19XQm1KNEZTbU1Ua3VGVlVCeENlaXkzREF1Q0x0QjVHLUZV?oc=5","date":"2016-03-30","type":"patent","source":"MarketsandMarkets","summary":"Biosimilars Market Report 2025-2035, By Drug Class, Indication, and Geo - MarketsandMarkets","headline":"Biosimilars Market Report 2025-2035, By Drug Class, Indication, and Geo","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}